CONCORD MEDICAL - SPON ADR
CCMNYSETrading Snapshot
- Day Range
- $3.71 β $3.71
- 52-Week Range
- β
- Volume (shares)
- 515
- Avg Volume (shares)
- β
- Shares Outstanding
- 130.3M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $461M
- Last Q Revenue
- $255M
- P/E Ratio
- β
- P/S Ratio
- 0.4x
- EPS (TTM)
- β
- Dividend Yield
- β
- Dilution (1yr)
- β0.6%
CONCORD MEDICAL - SPON ADR
CCMAbout CONCORD MEDICAL - SPON ADR
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peopleβs Republic of China. It operates in two segments, Network and Hospital. The companyβs services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.